Congrats to Mitchell Roitman of Psychology for being awarded funding from Novo Nordisk
Congratulations to Mitchell Roitman Director of Laboratory for Integrative Neuroscience of Psychology for being awarded funding from Novo Nordisk to study the effects of a new compound (alone and in combination with semaglutide) on reward sensitivity and dopamine signaling. The title of the project is: Investigating the effects of cagrilinitide, semaglutide and the combination (Cagri + Sema) on the encoding of value by the mesolimbic system.
Modified on March 25, 2024